Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-002628
Filing Date
2021-08-10
Accepted
2021-08-10 07:05:36
Documents
27
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2126392.htm   iXBRL 6-K 27855
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 300659
3 EXHIBIT 99.2 exhibit_99-2.htm   iXBRL EX-99 812467
9 GRAPHIC image00001.jpg GRAPHIC 3766
  Complete submission text file 0001178913-21-002628.txt   2501178

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mdwd-20210630.xsd EX-101.SCH 22869
5 XBRL CALCULATION FILE mdwd-20210630_cal.xml EX-101.CAL 38187
6 XBRL DEFINITION FILE mdwd-20210630_def.xml EX-101.DEF 33201
7 XBRL LABEL FILE mdwd-20210630_lab.xml EX-101.LAB 223717
8 XBRL PRESENTATION FILE mdwd-20210630_pre.xml EX-101.PRE 114077
10 EXTRACTED XBRL INSTANCE DOCUMENT zk2126392_htm.xml XML 189553
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36349 | Film No.: 211158396
SIC: 2833 Medicinal Chemicals & Botanical Products